DVA
US EQUITY
Health Care
Health Care Services
CIK: 927066
DaVita (DVA) Quant Factor Diagnostic & Fair Value Model
DaVita (Ticker: DVA) is listed in the Health Care sector (Health Care Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$183.64
-1.32%
Latest Close (2026-10-23)
Market Cap: $11.72B
P/E Ratio: 11.4
Momentum Strength
3M / 12M
-22.29%
1M: +5.14%
12M: +42.27%
Quality (ROE)
Point-in-Time
+98.35%
Trailing Return on Equity
Technical Trend
RSI 14
55.2
SMA50: $180.53
SMA200: $175.07
Valuation Multiplier
Trailing
11.4
Deep Value (Under 15x P/E)
📊
Valuation & Multi-Factor Diagnostic
Deep Value (Under 15x P/E)
DVA trades at an attractive earnings multiple of 11.4x, significantly lower than the broader S&P 500 average.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 7/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 927066 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-04 | $3.55B | $265.40M | $810.90M | $4.02 |
| 10-Q | 2025-12-31 | 2026-08-04 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-04 | $3.38B | $199.34M | $504.25M | $2.58 |
| 10-Q | 2026-03-31 | 2026-05-05 | $3.42B | $197.53M | $320.83M | $2.87 |
| 10-Q | 2025-03-31 | 2026-05-05 | $3.22B | $162.92M | $180.01M | $2.00 |
| 10-K | 2025-12-31 | 2026-02-11 | $13.64B | $746.80M | $1.89B | $9.84 |
| 10-K | 2024-12-31 | 2026-02-11 | $12.82B | $936.34M | $2.02B | $10.73 |
| 10-K | 2023-12-31 | 2026-02-11 | $12.14B | $691.53M | $2.06B | $7.42 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding DaVita (DVA) valuation multiples, momentum factors, and point-in-time filing conventions.
How should DVA's current valuation multiple be interpreted? ↓
DVA trades at a trailing P/E of 11.4x within the Health Care sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are DVA's key momentum and technical factor indicators? ↓
As of the latest close, DVA shows a 1-month return of +5.14%, 3-month return of -22.29%, and 12-month return of +42.27%, with a 14-day RSI of 55.2. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for DVA? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can DVA be incorporated into systematic factor models? ↓
DVA can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.